Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01375634 · ClinicalTrials.gov registry record · Phase 4
Nasogastric Tube Insertion Using Midazolam in the Emergency Department
A Phase 4 study, sponsored by University of Vermont.
- Completed
- Registry status
- Phase 4
- Development phase
- 49
- Enrollment target
NCT01375634 is a Phase 4 study that has completed, run by University of Vermont. The registered enrollment target is 49 participants.
The verdict
NCT01375634, a Phase 4 study, has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 49 participants
- Enrollment target
Study Summary
Nasogastric tube placement involves insertion of a flexible tube through the nose into the stomach. Placement of the tube can irritate the nose and palate and trigger gagging, causing discomfort, even if topical or local anesthetics are used. This study aims to determine if administration of an ultra-short acting sedative agent (midazolam) into a vein before the procedure, in addition to topical local anesthetic, will decrease the level of discomfort.
Interventions
- DRUG Midazolam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2011-05 |
| Est. Completion | 2013-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01375634
The ClinicalTrials.gov registry entry for NCT01375634 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Vermont, which has 162 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Midazolam is the first listed.
NCT01375634 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01375634 about?
NCT01375634 is a clinical study titled "Nasogastric Tube Insertion Using Midazolam in the Emergency Department". Nasogastric tube placement involves insertion of a flexible tube through the nose into the stomach. Placement of the tube can irritate the nose and palate and trigger gagging, causing discomfort, even if topical or local anesthetics are used. This study aims to determine if administration of an ultr...
What is the current status of trial NCT01375634?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 49 participants. The study started on 2011-05. Estimated completion is 2013-04.
What interventions are being tested in trial NCT01375634?
The interventions under investigation include: Midazolam (DRUG).
Who is sponsoring clinical trial NCT01375634?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.